News | March 23, 2024
Sharon Bio-Medicine resumes operations
Operations of Line II was stopped due to a fire incident earlier
Operations of Line II was stopped due to a fire incident earlier
Letermovir tablets, 240 mg and 480 mg had annual sales of USD 289.5 mn in the United States (IQVIA MAT Jan-24)
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
KarXT, Karuna’s lead asset, is a potential first-in-class treatment for Schizophrenia
Elegen is the only DNA manufacturer delivering the unique combination of complexity, length and NGS-verified accuracy within days
The plan essentially was to separate Aster’s India and GCC businesses to unlock long-term value
A five-day inspection was concluded successfully with no critical and no major observations raised
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ II, India
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
Chlorpromazine Hydrochloride Injection is used to treat certain mental/mood disorders
Subscribe To Our Newsletter & Stay Updated
